Menu
Search
|

Menu

Close
X

Tianjin Zhongxin Pharmaceutical Group Corp Ltd 600329.SS (Shanghai Stock Exchange)

12.94 CNY
-0.13 (-0.99%)
As of Feb 14
chart
Previous Close 13.07
Open 13.01
Volume 1,526,900
3m Avg Volume 2,457,118
Today’s High 13.11
Today’s Low 12.94
52 Week High 19.98
52 Week Low 12.51
Shares Outstanding (mil) 768.87
Market Capitalization (mil) 8,590.60
Forward P/E 23.03
Dividend (Yield %) 0.15 ( 1.93 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 2 analysts

KEY STATS

Revenue (mm, CNY)
FY17
4,294
FY16
6,227
FY15
7,081
EPS (CNY)
FY17
0.468
FY16
0.551
FY15
0.597
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
23.03
35.76
Price to Sales (TTM)
vs sector
1.50
8.59
Price to Book (MRQ)
vs sector
2.28
5.23
Price to Cash Flow (TTM)
vs sector
--
26.13
Total Debt to Equity (MRQ)
vs sector
10.99
15.32
LT Debt to Equity (MRQ)
vs sector
0.00
11.95
Return on Investment (TTM)
vs sector
9.71
13.59
Return on Equity (TTM)
vs sector
10.15
15.20

EXECUTIVE LEADERSHIP

Zhiqiang Wang
Chairman of the Board, General Manager, Since 2012
Salary: --
Bonus: --
Jun Sun
Chief Accounting Officer, Deputy General Manager, Director, Since 2012
Salary: --
Bonus: --
Daoqing Xu
Deputy General Manager, Chief Engineer, Director, Since 2012
Salary: --
Bonus: --
Jian Zhang
Deputy General Manager, Since 2008
Salary: --
Bonus: --
Lei Wang
Executive Director, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

No. 17, Baidi Road, Nankai Distr
TIANJIN   TNJ   300193

Phone: +8622.27020892

TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CORPORATION LIMITED is a China-based company mainly engaged in the development, manufacture and distribution of pharmaceutical products. The Company’s main products include Chinese patent medicines, western medicines, Chinese medicinal materials, pharmaceutical raw materials and preparations, biological medicines, dietary supplements and other products. The Company’s main products consist of drugs for treatment of cardiovascular diseases and enterogastritis, respiratory drugs, as well as antineoplastic drugs, among others. It distributes its products within domestic market and to overseas markets.

SPONSORED STORIES